New providing offers well being programs a option to decide whether or not their healthcare knowledge aligns with pharmaceutical demand earlier than participating or dedicating assets.
September 16, 2025 — Beaverton, OR — knowledge, a frontrunner in federated real-world knowledge entry, at present introduced the Federated Biomarker Explorer for Well being Methods, a brand new device that offers hospitals, most cancers facilities, and labs a option to validate pharmaceutical demand for his or her knowledge earlier than committing to an information partnership or investing inner effort. Well being programs excited by previewing pharma demand for his or her knowledge can register now for early entry.
This newest utility for well being programs enhances the Federated Biomarker Explorer for Pharma, launched in July, which permits pharmaceutical and life sciences customers to evaluate real-world knowledge feasibility throughout datma’s federated community. Collectively, these choices will allow knowledge custodians and knowledge shoppers to validate alignment earlier and extra effectively, with out danger or obligation.
Well being knowledge performs a big position in oncology analysis and precision medication, however that doesn’t all the time translate into measurable return. In lots of knowledge sharing preparations, well being programs are requested to speculate assets up entrance with out understanding if their knowledge will probably be used, when it’d generate worth, or whether or not it aligns with energetic pharmaceutical wants. When utilization is unclear, so is return on funding, leaving establishments unsure about when, or if, their participation will repay.
“Well being programs shouldn’t must guess whether or not their knowledge has instant worth to pharma,” stated Robin Edison, VP of Product at datma. “Now they don’t. This device lets them know precisely when their knowledge is required, and when collaborating will create instant worth.”
A Extra Strategic Approach to Have interaction
Taking part well being programs present a high-level abstract of their out there knowledge, reminiscent of most cancers varieties, biomarker findings, and cohort sizes. No affected person knowledge is shared, and no technical integration or authorized settlement is required at this stage. These summaries are made seen within the Federated Biomarker Explorer to vetted pharma and life sciences customers conducting feasibility searches for real-world knowledge. . When a match is recognized, datma alerts the well being system immediately, and well being programs have a transparent alternative to take part in datma.FED with instant return on demand already in place. From there, the establishment decides whether or not to interact. Participation is optionally available and could be up to date or withdrawn at any time.
Eliminating Uncertainty in Information Partnerships
Many well being programs have explored knowledge sharing partnerships solely to face unclear timelines, restricted utilization, or stalled outcomes. Some have made early investments with real-world knowledge aggregators and seen little or no return.
The Federated Biomarker Explorer reverses that dynamic by permitting establishments to behave solely when actual demand has been confirmed. It shortens the trail to worth whereas eliminating the chance of wasted inner effort.
“This mannequin creates alignments earlier than any dedication,” stated Noah Nasser, CEO of datma. “Well being programs can now have interaction with confidence, understanding there’s an actual use case.”
Validating Demand from Each Sides
With the launch of each the Pharma and Well being System Federated Biomarker Explorer, datma now helps bidirectional validation throughout its federated community. Pharma groups can consider real-world knowledge protection to evaluate feasibility. Well being programs can see when their knowledge is in demand earlier than participating. Neither occasion is requested to maneuver ahead till there’s a transparent, confirmed sign, serving to each side scale back danger and act with larger confidence.
The Federated Biomarker Explorer for Well being Methods is offered for early entry registration at present. To be taught extra and be a part of the early entry checklist, go to https://www.datma.com/health-trial.
About datma
datma is remodeling how healthcare is accessed and shared by means of a safe, federated ecosystem that allows collaboration between knowledge custodians and knowledge shoppers. Headquartered in Beaverton, OR, datma’s flagship platform, datma.FED powers a two sided market for real-world healthcare knowledge that helps compliant, privacy-preserving collaboration with out requiring knowledge to maneuver or sacrificing institutional management. datma.FED leverages superior knowledge storage, AI-enabled instruments for harmonizing multimodal datasets, and federated question capabilities. The platform is designed to maximise knowledge utility whereas requiring minimal technical effort from collaborating organizations. It permits knowledge custodians to generate secondary income streams and reinvest in innovation whereas sustaining management over their knowledge, whereas serving to knowledge shoppers entry various, high-quality, de-identified knowledge that augments current datasets and helps proof era at scale. By addressing longstanding challenges in knowledge entry, privateness, and utility, datma.FED helps the proof era wanted to advance precision medication. For extra data, go to www.datma.com.
Media Contact:
Vikki Herrera
Oak Road Communications
vikki@oakstreetcommunications.com
